Synthetic (+)‐antroquinonol exhibits dual actions against insulin resistance by triggering AMP kinase and inhibiting dipeptidyl peptidase IV activities
Hsu, C Y, Sulake, R S, Huang, P‐K, Shih, H‐Y, Sie, H‐W, Lai, Y‐K, Chen, C, Weng, C F
Published in British journal of pharmacology (01.01.2015)
Published in British journal of pharmacology (01.01.2015)
Get full text
Journal Article